Nancy A. Dawson

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles et al. · The Lancet · 2016 · 3.7K citations · Full text

Urology, Metastatic Urothelial Carcinoma, Genitourinary Cancer +8

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg et al. · The Lancet · 2016 · 2.2K citations · Full text

Urology, Genitourinary Cancer, Medicine +7

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Glenn J. Bubley, Michael A. Carducci, William L. Dahut et al. · Journal of Clinical Oncology · 1999 · 979 citations

Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer

Susan Halabi, Eric J. Small, Philip W. Kantoff et al. · Journal of Clinical Oncology · 2003 · 677 citations

Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

Maha Hussain, Catherine M. Tangen, Donna L. Berry et al. · New England Journal of Medicine · 2013 · 562 citations · Full text